Hong Wen, Ph.D.

Professor, Department of Epigenetics

Areas of Expertise

Chromatin, transcription, histone modifications, epigenetics, leukemia, pediatric cancers

Biography

Dr. Hong Wen earned her B.S. in biochemistry from Wuhan University and her Ph.D. in biochemistry and molecular biology from the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, both with honors. She subsequently served as a postdoctoral fellow in the Department of Pathology at Stanford University. She joined the Department of Biochemistry and Molecular Biology at University of Texas MD Anderson Cancer Center as an assistant professor in 2008 and was promoted to associate professor in the Department of Epigenetics and Molecular Carcinogenesis in 2017. Dr. Wen joined Van Andel Institute in 2018 as an associate professor in the Department of Epigenetics and was promoted to professor in 2023. She is an epigenetics expert who investigates the molecular underpinnings of pediatric cancers, with a focus on how epigenetic dysregulation impacts gene expression and drives malignancy. She is also committed to developing new improved epigenetic therapies for cancer treatment. Dr. Wen is an awardee of Career Development Program Scholar from the Leukemia & Lymphoma Society.